The SARS-CoV-2 spike protein triggers a wide range of symptoms by binding to ACE2 receptors on cells throughout the body, setting off inflammation, blood vessel damage, clotting abnormalities, and immune dysregulation. These effects can appear during acute COVID-19 infection, in some cases after vaccination, and in the persistent form known as long COVID. Because ACE2 receptors sit on cells in the lungs, heart, brain, gut, kidneys, and blood vessels, the symptom profile is unusually broad, and that breadth is part of what makes spike-related illness so confusing to patients and clinicians alike.
How the Spike Protein Starts Trouble
The spike protein’s primary job, from the virus’s perspective, is to latch onto ACE2 receptors on the surface of human cells and open the door for infection. But that binding event does more than let the virus in. It pulls ACE2 off the cell surface, reducing the amount of functional ACE2 available. ACE2 normally helps regulate blood pressure, inflammation, and fluid balance by breaking down a molecule called angiotensin II. When ACE2 levels drop, angiotensin II accumulates, and that excess drives up blood pressure, promotes inflammation, and can damage multiple organ systems.1PubMed Central. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications Research has confirmed that this ACE2 reduction is caused specifically by the spike protein rather than other viral components, and the effect is dose-dependent: more spike protein means less ACE2.2Journal of Infection. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection
This ACE2 disruption is the upstream event behind many of the symptoms people experience, but it is not the only mechanism. The spike protein also directly activates immune receptors called toll-like receptors on immune cells, essentially tripping the body’s alarm system even in places where viral replication may not be happening. Spike protein activates TLR2, triggering a signaling cascade that switches on the inflammatory master switch NF-κB, which in turn floods the area with inflammatory cytokines and chemokines.3eLife. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway The S1 subunit of the spike also activates TLR4 signaling in macrophages, amplifying the inflammatory response further.4Heliyon. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages In severe cases, this cascade feeds on itself: spike-stimulated T cells overproduce certain signaling molecules, which ramp up monocyte activation, which sustains the interaction between spike and TLR4, keeping the inflammatory loop going.5PubMed Central. SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2
The practical result of all this immune activation is what people experience as fever, body aches, fatigue, and that general feeling of being profoundly unwell. When the cytokine response spirals out of control, as it can in severe COVID-19, it becomes the “cytokine storm” associated with organ failure and critical illness.
Blood Vessel Damage and Clotting
One of the most distinctive aspects of spike protein activity is its effect on blood vessels. The spike protein triggers inflammation in endothelial cells, the cells lining every blood vessel in the body, even without active viral replication taking place. Exposure to the S1 subunit of the spike protein causes endothelial cells to release microparticles (a marker of cellular injury) and to proliferate abnormally.6Scientific Reports. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication The symptoms that follow from endothelial damage are varied because blood vessels run everywhere: chest tightness, headaches, skin flushing, elevated blood pressure, and poor circulation in the extremities can all trace back to inflamed, dysfunctional vessel walls.
Clotting abnormalities are a particularly serious downstream consequence. The spike protein binds directly to fibrinogen, the blood protein that forms the scaffolding of clots, and produces structurally abnormal clots with heightened inflammatory properties.7PubMed Central. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy Adding to the problem, the spike protein changes the structure of fibrinogen in ways that make the resulting clots resistant to the body’s normal clot-dissolving machinery. This resistance to breakdown can lead to persistent microclots, tiny clots that clog small blood vessels and may contribute to the ongoing fatigue, exercise intolerance, and cognitive problems seen in long COVID.8PubMed Central. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19 Laboratory work has shown that amyloid-like fibrils formed from spike protein fragments can further impair the ability of clots to dissolve properly.9Biochemistry. SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis
For patients, this clotting tendency shows up as unexplained deep vein thrombosis, pulmonary embolism in severe cases, or subtler signs like persistent cold fingers and toes, skin discoloration, and exercise intolerance disproportionate to any measured heart or lung damage.
Neurological Symptoms and Brain Fog
Brain fog is perhaps the most commonly reported persistent symptom linked to spike protein activity, and research has begun to explain why. The spike protein’s S1 subunit directly damages brain endothelial cells, the cells that form the blood-brain barrier. Exposure to S1 protein causes these cells to ramp up production of inflammatory molecules and cell adhesion molecules in a dose-dependent fashion, essentially making the blood-brain barrier leaky and inflamed.10PubMed Central. Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment Separately, the spike protein triggers activation of a signaling molecule called RhoA in barrier cells, which disassembles the tight junctions that normally keep the barrier sealed.11PubMed Central. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation
When the blood-brain barrier loses integrity, inflammatory molecules and immune cells from the bloodstream can enter brain tissue where they normally would not go. The result is neuroinflammation, which patients experience as difficulty concentrating, memory lapses, word-finding trouble, mental fatigue after even light cognitive effort, and a pervasive sense of mental cloudiness. Some people also report headaches, dizziness, and changes in smell or taste, all of which may relate to this barrier disruption and the broader neuroinflammatory state. Animal studies tracking the distribution of labeled spike protein have found that after the lungs, the brain showed the highest spike protein uptake, underscoring why neurological symptoms are so prominent.12Trends in Microbiology. The spike protein of SARS-CoV-2 induces endothelial dysfunction: potential repair mechanisms and therapeutic interventions
Heart and Chest Symptoms
Cardiac symptoms linked to spike protein activity range from chest pain and palpitations to clinically diagnosed myocarditis, inflammation of the heart muscle. Research into cases of post-vaccination myocarditis found markedly elevated levels of free-floating, full-length spike protein in the blood of affected individuals, averaging around 34 pg/mL, while vaccinated people without myocarditis had no detectable free spike protein.13PubMed Central. Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis The immune profiles of the myocarditis patients were otherwise similar to healthy vaccinated people, pointing to the unbound spike itself as a driver of the cardiac inflammation rather than a general immune overreaction.
At a cellular level, the spike protein impairs mitochondrial function in heart muscle cells over time. Within the first day of exposure, heart cells ramp up their energy production as if under stress. By three days, that compensation collapses: the cells’ mitochondrial membrane potential drops, energy production falls, and damaging reactive oxygen species accumulate. This creates a cycle where mitochondrial damage produces more oxidative stress, which worsens mitochondrial damage further.14PubMed Central. Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19 Patients may feel this as chest pressure, shortness of breath with minimal exertion, palpitations, or a sense that their heart is working harder than it should at rest.
Gut Symptoms
Gastrointestinal complaints during and after COVID-19, including nausea, diarrhea, abdominal pain, and loss of appetite, have a direct link to spike protein activity. The gut lining is rich in ACE2 receptors, making it a prime target. Research shows the spike protein disrupts the gut’s mucosal barrier from the outer protective layer all the way to deeper tissue. It damages specialized cells that produce protective mucus and antimicrobial compounds, weakens the tight junctions between intestinal cells, and increases intestinal permeability, colloquially known as “leaky gut.”15PubMed. SARS-CoV-2 Spike protein triggers gut impairment since mucosal barrier to innermost layers: From basic science to clinical relevance
The spike protein also provokes intestinal inflammation through a specific pathway in the cells lining the intestine. It stimulates overproduction of VEGF, a signaling molecule that increases blood vessel permeability, in the duodenum. That VEGF then leaks into the bloodstream, contributing to both local intestinal inflammation and systemic vascular effects.16PubMed Central. SARS‐CoV‐2 spike spurs intestinal inflammation via VEGF production in enterocytes This mechanism helps explain why gut symptoms sometimes appear alongside vascular symptoms in the same patient, and why some people develop food sensitivities or worsened irritable bowel symptoms that persist well beyond the acute infection.
Autonomic Dysfunction and POTS
A subset of people exposed to spike protein develop dysautonomia, a malfunction of the autonomic nervous system that controls heart rate, blood pressure, digestion, and temperature regulation. The most recognized form is postural orthostatic tachycardia syndrome, or POTS, where standing up causes an excessive increase in heart rate along with dizziness, lightheadedness, and sometimes fainting. Spike protein contributes to POTS through direct neurotoxic effects and by disrupting the renin-angiotensin system via ACE2 downregulation.17PubMed Central. COVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
Deep phenotyping of long-COVID POTS patients has found that roughly one in five has measurably reduced small nerve fiber density in the legs, following a length-dependent pattern consistent with small fiber neuropathy.18medRxiv. Long-COVID Postural Tachycardia Syndrome: A deep phenotyping study Small fiber neuropathy can cause burning pain, tingling, and numbness in the feet and hands, on top of the cardiovascular instability. Patients often describe a constellation that includes rapid heartbeat upon standing, exercise intolerance, temperature sensitivity, digestive irregularity, and unpredictable blood pressure swings, all stemming from the same autonomic disruption.
Mast Cell Activation and Allergic-Type Reactions
Some of the more puzzling symptoms people report, including hives, flushing, itching, throat tightness, and reactions to foods or chemicals they previously tolerated, may trace to spike protein’s ability to activate mast cells. Mast cells are immune sentinels loaded with histamine and other inflammatory mediators. Research has shown that spike proteins from coronaviruses trigger mast cells to degranulate, releasing their contents, through a specific signaling cascade involving src kinase and the PI3K/AKT pathway, culminating in a surge of intracellular calcium that pushes the granules out.19PubMed Central. Spike proteins of coronaviruses activate mast cells for degranulation via stimulating Src/PI3K/AKT/Ca2+ intracellular signaling cascade
When mast cells degranulate excessively or inappropriately, the resulting histamine flood can cause symptoms that look like an allergic reaction without an obvious allergen: skin rashes, abdominal cramping, rapid heart rate, flushing, and a sensation of whole-body inflammation. Many long-COVID patients who report new chemical sensitivities or worsening allergies may be experiencing this mast cell activation. Antihistamines and mast cell stabilizers have become part of the symptom-management toolkit for these patients, though formal clinical trial evidence for this approach is still limited.
Skin Manifestations
Dermatological symptoms linked to spike protein include “COVID toes,” a condition resembling chilblains where the toes (and sometimes fingers) become swollen, red or purple, and painful. Biopsy studies of these perniotic skin lesions have detected spike protein in the endothelial cells and sweat gland epithelium of affected tissue, even when viral RNA was absent, suggesting that cleaved spike protein can deposit in skin tissue and trigger local endothelial inflammation independently of active viral replication.20PubMed. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein Other skin manifestations reported in the literature include urticaria (hives), livedo reticularis (a mottled, net-like discoloration), and various rashes, many of which likely involve the same endothelial and mast cell mechanisms described above.
Thyroid and Hormonal Disruption
The thyroid gland expresses ACE2, making it vulnerable to spike protein binding. COVID-19 has been associated with new-onset thyroid disease and worsening of existing thyroid conditions, including both overactive and underactive thyroid function as well as autoimmune thyroid inflammation.21Journal of Translational Autoimmunity. SARS-CoV-2 and thyroid diseases The thyroid is sensitive to shifts in the body’s inflammatory and metabolic state, so the systemic inflammation driven by spike protein activity can disrupt thyroid hormone regulation even without the virus directly infecting thyroid tissue. Symptoms of thyroid disruption include unexplained weight changes, temperature intolerance, hair loss, fatigue, and mood disturbances, which can easily be attributed to “just feeling off” after COVID without anyone checking thyroid function.
Why Symptoms Can Persist for Months
One of the more unsettling findings in spike protein research is that the protein does not always leave the body promptly. People with post-acute sequelae of COVID-19 (the clinical term for long COVID) often have detectable spike protein in their blood for months, and in some cases more than a year after their initial infection. This persistence suggests the protein may be stored in cellular reservoirs and periodically released back into the bloodstream, where it can continue causing endothelial damage and immune activation.22Frontiers in Cellular Neuroscience. Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC
Interestingly, spike protein persistence does not always correlate with the same immune markers. Research measuring both circulating spike protein and immune dysregulation markers in long-COVID patients found that the presence of spike protein did not track with markers of macrophage activation, indicating that persistent spike and immune dysregulation may represent independent mechanisms driving symptoms in different subsets of patients.23PubMed Central. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19 This biological heterogeneity helps explain why long COVID looks so different from one person to the next, and why no single treatment works for everyone.
Molecular Mimicry and Autoimmune Symptoms
Beyond direct tissue damage, the spike protein may set the stage for autoimmune problems through molecular mimicry, where short sequences of the spike protein closely resemble sequences in human proteins. The immune system, trained to attack the spike, can sometimes cross-react with the body’s own tissues. Bioinformatic analyses have identified several human proteins with regions similar enough to spike protein sequences to potentially be targeted by cross-reactive antibodies, including proteins involved in blood clotting, calcium regulation, and cardiac muscle function.24PubMed Central. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
One particularly well-characterized example involves a motif shared between the spike protein and thrombopoietin, a hormone critical for platelet production. Antibodies targeting the spike could cross-react with thrombopoietin, potentially causing low platelet counts, a condition that has indeed been observed in COVID-19 patients. Other shared motifs involve proteins related to platelet activation and heart muscle, offering plausible molecular explanations for the clotting disorders and cardiac complications seen in some patients.24PubMed Central. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins A broader analysis identified additional human proteins with homologous regions to the spike, including some involved in cell adhesion and neural development, that could theoretically become autoimmune targets.25PubMed Central. SARS-CoV-2 Spike Protein and Molecular Mimicry: An Immunoinformatic Screen for Cross-Reactive Autoantigen Candidates These findings are largely computational and preclinical at this stage, but they provide a framework for understanding why some people develop new autoimmune conditions months after COVID-19.
Cell Fusion and Tissue Damage
A less widely discussed mechanism is the spike protein’s ability to cause neighboring cells to fuse into large, dysfunctional structures called syncytia. When spike protein on the surface of an infected cell encounters ACE2 on an adjacent uninfected cell, it can pull the two cell membranes together, merging them. These fused cell masses can facilitate viral spread from cell to cell without the virus ever entering the bloodstream, help the virus evade immune detection, and amplify the inflammatory response in affected tissue.26PubMed Central. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation Syncytia formation has been observed in lung tissue from severe COVID-19 cases and may contribute to the extensive tissue destruction seen in some patients’ lungs, helping explain why some people suffer prolonged respiratory symptoms and impaired gas exchange even after the virus itself has been cleared.
After Vaccination Versus After Infection
An important distinction readers often want understood is whether spike protein from mRNA vaccines behaves the same way as spike protein from infection. In the vaccination context, spike protein is produced transiently by cells at the injection site. A study tracking the distribution of vaccine-related mRNA and spike protein in humans found that expression was concentrated at the vaccination site, primarily in muscle-associated fibroblasts rather than immune cells. In that study, vaccine-related spike protein was not detected in organs beyond the injection site in human participants, though it was found in several organs in mice up to seven days after vaccination.27PubMed Central. Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans
The rare cases of post-vaccination myocarditis, as noted earlier, were specifically associated with free spike protein circulating in the blood unbound by antibodies. This suggests that in the vast majority of vaccinated people, antibodies neutralize the spike protein before it can cause significant endothelial or organ damage. Infection, by contrast, produces far more spike protein over a longer period and distributes it throughout the body via the bloodstream. The quantity and duration of spike protein exposure during moderate-to-severe COVID-19 dwarfs what occurs after vaccination, which is why serious spike-related complications are considerably more common after infection than after immunization.